Investigating Trends in Quality of Life in Patients with Idiopathic Pulmonary Fibrosis (IPF) Under Treatment with Nintedanib (QUALIFY IPF)

08/10/2018
19/10/2026
EU PAS number:
EUPAS25664
Study
Finalised
Documents
Study protocol
Initial protocol
English (748.74 KB - PDF) View document
Study results
Study results
English (483.06 KB - PDF) View document
Study report
No information provided.
ENCePP Seal
No information provided.